
Overview
Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis.
Dr. Scola is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.
Dr. Scola is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 1 clinical trial. Dr. Scola is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Madison Avenue, Morristown, NJ 07960
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Carol G. Simon Cancer Center
Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.
Atlantic Medical Group Hematology Oncology
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.
Atlantic Hematology Oncology
"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.
Garden State Urology
The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction. Dr. Prasad is board certified in American Board Of Urology. Dr. Prasad is currently accepting new patients.
Atlantic Women's Cancer Associates
Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Salpingo-Oophorectomy. Dr. Tchabo is board certified in American Board Of Obstetrics And Gynecology. Dr. Tchabo is currently accepting new patients.
Atlantic Women's Cancer Associates
Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Bladder Reconstruction, and Hernia Surgery. Dr. Tobias is board certified in American Board Of Obstetrics And Gynecology. Dr. Tobias is currently accepting new patients.
Frequently Asked Questions about Dr. Michael A. Scola
How do I make an appointment with Dr. Michael A. Scola?
You can book an appointment with Dr. Michael A. Scola by calling their office at 973-971-7960. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael A. Scola a top-rated expert for Philadelphia-Negative Chronic Myeloid Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael A. Scola is classified as an Distinguished expert for Philadelphia-Negative Chronic Myeloid Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael A. Scola specialize in?
While Dr. Michael A. Scola is a Hematology, they have specific expertise in Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Michael A. Scola participate in research or clinical trials?
Yes. Dr. Michael A. Scola has published 1 articles and abstracts on conditions like Philadelphia-Negative Chronic Myeloid Leukemia. You can view a list of Dr. Michael A. Scola's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael A. Scola accept my insurance?
Dr. Michael A. Scola accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 973-971-7960 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Scola isDistinguished. Learn about Anemia.
- Chronic Myelogenous Leukemia (CML)Dr. Scola isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Familial Pancreatic CancerDr. Scola isDistinguished. Learn about Familial Pancreatic Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Non-Hodgkin LymphomaDr. Scola isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Advanced
- AgranulocytosisDr. Scola isAdvanced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Scola isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)Dr. Scola isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Scola isAdvanced. Learn about Chronic Familial Neutropenia.
- Chronic Lymphocytic Leukemia (CLL)
- Classical Hodgkin LymphomaDr. Scola isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Endometrial CancerDr. Scola isAdvanced. Learn about Endometrial Cancer.
- Essential ThrombocythemiaDr. Scola isAdvanced. Learn about Essential Thrombocythemia.
- Gastric LymphomaDr. Scola isAdvanced. Learn about Gastric Lymphoma.
- Heyde SyndromeDr. Scola isAdvanced. Learn about Heyde Syndrome.
- Hodgkin LymphomaDr. Scola isAdvanced. Learn about Hodgkin Lymphoma.
- Idiopathic NeutropeniaDr. Scola isAdvanced. Learn about Idiopathic Neutropenia.
- Lung CancerDr. Scola isAdvanced. Learn about Lung Cancer.
- Malignant Mixed Mullerian TumorDr. Scola isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Multiple MyelomaDr. Scola isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Scola isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Ovarian CancerDr. Scola isAdvanced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Scola isAdvanced. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Scola isAdvanced. Learn about Paget Disease of the Breast.
- Pancreatic CancerDr. Scola isAdvanced. Learn about Pancreatic Cancer.
- Pleuropulmonary BlastomaDr. Scola isAdvanced. Learn about Pleuropulmonary Blastoma.
- Polycythemia VeraDr. Scola isAdvanced. Learn about Polycythemia Vera.
- Richter SyndromeDr. Scola isAdvanced. Learn about Richter Syndrome.
- Schnitzler SyndromeDr. Scola isAdvanced. Learn about Schnitzler Syndrome.
- Sertoli-Leydig Cell TumorDr. Scola isAdvanced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Scola isAdvanced. Learn about Testicular Yolk Sac Tumor.
- ThrombocytopeniaDr. Scola isAdvanced. Learn about Thrombocytopenia.
- Virilizing Ovarian TumorDr. Scola isAdvanced. Learn about Virilizing Ovarian Tumor.
- Von Willebrand Disease (VWD)Dr. Scola isAdvanced. Learn about Von Willebrand Disease (VWD).
- Experienced
- Acute Eosinophilic PneumoniaDr. Scola isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Scola isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Scola isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Scola isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adrenal CancerDr. Scola isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Scola isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Scola isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Scola isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Scola isExperienced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Scola isExperienced. Learn about Antiphospholipid Syndrome.
- Aplastic AnemiaDr. Scola isExperienced. Learn about Aplastic Anemia.
- Autoimmune Hemolytic AnemiaDr. Scola isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Scola isExperienced. Learn about B-Cell Lymphoma.
- Beta ThalassemiaDr. Scola isExperienced. Learn about Beta Thalassemia.
- Bladder CancerDr. Scola isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Scola isExperienced. Learn about Bone Tumor.
- Breast CancerDr. Scola isExperienced. Learn about Breast Cancer.
- Cardiac AmyloidosisDr. Scola isExperienced. Learn about Cardiac Amyloidosis.
- Castleman DiseaseDr. Scola isExperienced. Learn about Castleman Disease.
- Cerebral Amyloid AngiopathyDr. Scola isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Cervical CancerDr. Scola isExperienced. Learn about Cervical Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Scola isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Scola isExperienced. Learn about Colorectal Cancer.
- Deep Vein ThrombosisDr. Scola isExperienced. Learn about Deep Vein Thrombosis.
- Desmoplastic Small Round Cell TumorDr. Scola isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Scola isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Ear CancerDr. Scola isExperienced. Learn about Ear Cancer.
- EGFR Positive Lung CancerDr. Scola isExperienced. Learn about EGFR Positive Lung Cancer.
- Epithelioid SarcomaDr. Scola isExperienced. Learn about Epithelioid Sarcoma.
- Familial Colorectal CancerDr. Scola isExperienced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Scola isExperienced. Learn about Familial Prostate Cancer.
- Febrile NeutropeniaDr. Scola isExperienced. Learn about Febrile Neutropenia.
- FibrosarcomaDr. Scola isExperienced. Learn about Fibrosarcoma.
- Follicular LymphomaDr. Scola isExperienced. Learn about Follicular Lymphoma.
- Gallbladder AdenocarcinomaDr. Scola isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Scola isExperienced. Learn about Gallbladder Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Gastroesophageal Junction CancerDr. Scola isExperienced. Learn about Gastroesophageal Junction Cancer.
- Gastrointestinal Stromal TumorDr. Scola isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Hairy Cell Leukemia (HCL)Dr. Scola isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Hemangioma Thrombocytopenia SyndromeDr. Scola isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- HemosiderosisDr. Scola isExperienced. Learn about Hemosiderosis.
- Hereditary Cerebral Amyloid Angiopathy
- Hereditary NeuroblastomaDr. Scola isExperienced. Learn about Hereditary Neuroblastoma.
- Hypereosinophilic SyndromeDr. Scola isExperienced. Learn about Hypereosinophilic Syndrome.
- Idiopathic Pulmonary HemosiderosisDr. Scola isExperienced. Learn about Idiopathic Pulmonary Hemosiderosis.
- Immune Thrombocytopenic Purpura (ITP)Dr. Scola isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Inflammatory Breast CancerDr. Scola isExperienced. Learn about Inflammatory Breast Cancer.
- Large-Cell Immunoblastic LymphomaDr. Scola isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Large-Cell Lung CarcinomaDr. Scola isExperienced. Learn about Large-Cell Lung Carcinoma.
- LiposarcomaDr. Scola isExperienced. Learn about Liposarcoma.
- Lung AdenocarcinomaDr. Scola isExperienced. Learn about Lung Adenocarcinoma.
- Lymphofollicular HyperplasiaDr. Scola isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lynch SyndromeDr. Scola isExperienced. Learn about Lynch Syndrome.
- MAGIC SyndromeDr. Scola isExperienced. Learn about MAGIC Syndrome.
- Mantle Cell Lymphoma (MCL)Dr. Scola isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Mediastinal TumorDr. Scola isExperienced. Learn about Mediastinal Tumor.
- MesenchymomaDr. Scola isExperienced. Learn about Mesenchymoma.
- Metastatic Pleural TumorDr. Scola isExperienced. Learn about Metastatic Pleural Tumor.
- Multicentric Castleman Disease (MCD)Dr. Scola isExperienced. Learn about Multicentric Castleman Disease (MCD).
- Muscle Invasive Bladder CancerDr. Scola isExperienced. Learn about Muscle Invasive Bladder Cancer.
- MyelofibrosisDr. Scola isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Scola isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Myxoid LiposarcomaDr. Scola isExperienced. Learn about Myxoid Liposarcoma.
- NeuroblastomaDr. Scola isExperienced. Learn about Neuroblastoma.
- Neuroendocrine TumorDr. Scola isExperienced. Learn about Neuroendocrine Tumor.
- Non-Muscle Invasive Bladder CancerDr. Scola isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Scola isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PancreatoblastomaDr. Scola isExperienced. Learn about Pancreatoblastoma.
- Primary Immunodeficiency (PID)Dr. Scola isExperienced. Learn about Primary Immunodeficiency (PID).
- Primary Localized Cutaneous Amyloidosis
- Primary Lymphoma of the BrainDr. Scola isExperienced. Learn about Primary Lymphoma of the Brain.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Prostate CancerDr. Scola isExperienced. Learn about Prostate Cancer.
- Pulmonary EmbolismDr. Scola isExperienced. Learn about Pulmonary Embolism.
- Relapsed Refractory Multiple Myeloma (RRMM)
- ReticuloendotheliosisDr. Scola isExperienced. Learn about Reticuloendotheliosis.
- Rhabdomyosarcoma EmbryonalDr. Scola isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Severe Congenital NeutropeniaDr. Scola isExperienced. Learn about Severe Congenital Neutropenia.
- Small Cell Lung Cancer (SCLC)Dr. Scola isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Small Lymphocytic Lymphoma (SLL)Dr. Scola isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Smoldering Multiple MyelomaDr. Scola isExperienced. Learn about Smoldering Multiple Myeloma.
- SplenomegalyDr. Scola isExperienced. Learn about Splenomegaly.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Squamous Cell Lung CarcinomaDr. Scola isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Stomach CancerDr. Scola isExperienced. Learn about Stomach Cancer.
- ThalassemiaDr. Scola isExperienced. Learn about Thalassemia.
- Undifferentiated Pleomorphic SarcomaDr. Scola isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Unicentric Castleman Disease (UCD)Dr. Scola isExperienced. Learn about Unicentric Castleman Disease (UCD).
- Urothelial CancerDr. Scola isExperienced. Learn about Urothelial Cancer.
- Vitamin B12 DeficiencyDr. Scola isExperienced. Learn about Vitamin B12 Deficiency.
- Vulvar CancerDr. Scola isExperienced. Learn about Vulvar Cancer.
- Waldenstrom MacroglobulinemiaDr. Scola isExperienced. Learn about Waldenstrom Macroglobulinemia.





